When standard procedures fail, doctors may still be able to diagnose Cushing’s disease by sampling blood from veins near…
Articles by Marisa Wexler, MS
People with Cushing’s syndrome commonly lose weight after the disorder is treated, a new study found. Findings indicate that nearly…
The first participant has been dosed in a Phase 2 clinical trial testing ST-002 in people with Cushing’s syndrome and…
Treatment with Isturisa (osilodrostat) was found to be effective for reducing cortisol levels in people with Cushing’s disease…
Cognitive issues are most common in people with Cushing’s disease who have high cortisol levels in the morning, high…
The U.S. Food and Drug Administration (FDA) has approved Isturisa (osilodrostat) to treat adults with all forms of endogenous…
A clinical trial aims to assess the prevalence of Cushing’s syndrome in adults with hard-to-treat high blood pressure. The…
The U.S. Food and Drug Administration (FDA) has accepted an application from Corcept Therapeutics seeking the approval of…
Sterotherapeutics has announced the launch of a Phase 2 clinical trial to test its experimental therapy ST-002 in…
In rare cases, Cushing’s syndrome can be caused by tumors that are simultaneously producing two signaling molecules called adrenocorticotropic hormone…